Baxalta Inc. (BXLT), which has received an unsolicited $30.6 billion takeover bid from Shire PLC (SHPG, SHP.LN), is in talks to buy Ariad Pharmaceuticals Inc. (ARIA), Bloomberg News reported Friday, citing people with knowledge of the matter.

Ariad shares recently traded up 42% to $9.93.

The Bloomberg report said there is no certainty of a deal and that Baxalta may pursue other targets.

Full story at http://www.bloomberg.com/news/articles/2015-08-28/baxalta-said-in-talks-to-buy-drugmaker-to-bolster-independence

Write to nymonitoring@dowjones.com

 

Subscribe to WSJ: http://online.wsj.com?mod=djnwires

(END) Dow Jones Newswires

August 28, 2015 15:27 ET (19:27 GMT)

Copyright (c) 2015 Dow Jones & Company, Inc.
Ariad (NASDAQ:ARIA)
Historical Stock Chart
From Feb 2024 to Mar 2024 Click Here for more Ariad Charts.
Ariad (NASDAQ:ARIA)
Historical Stock Chart
From Mar 2023 to Mar 2024 Click Here for more Ariad Charts.